The binding of estradiol in the uterus: a mechanism for derepression of RNA synthesis by Talwar, G. P. et al.
\ OL. 52, 1964 BIOCHEMISTRY: TALWAR ET AL. 1059
erologous, and reciprocal) of the four viral DNA's. The DNA's of tumorigenic
adenovirus types 12 and 18 hybridized with each other to the extent of 79 per cent,
indicating a high degree of genetic homology; those of adenovirus types 2 and 4
hybridized 35 per cent indicating that they are about half as related to each other
as are the tumorigenic types. The DNA's of tumorigenic adenovirus types hy-
bridized with those of the nontumorigenic adenovirus types only to the extent of
18-26 per cent, suggesting that the nucleotide sequences in most of their cistrons
are dissimilar.
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Constance Self in the preparation of some of these viruses.
* This research was supported by grant AI-01725 of the National Institutes of Health.
t Predoctoral trainee supported by training grant T1-GM-151.
I Research Career Awardee of the National Institutes of Health. 
1 Huebner, R. J., W. P. Rowe, and W. T. Lane, these PROCEEDINGS, 48, 2051 (1962).
2 Trentin, J. J., Y. Yabe, and G. Taylor, Science, 137, 835 (1962).
3 Green, M. and M. Pifia, these PROCEEDINGS, 50, 44 (1963).
4Ibid., 51, 1251 (1964).
5 Bolton, E. T., and B. J. McCarthy, these PROCEEDINGS, 48, 1390 (1962).
6 McCarthy, B. J., and E. T. Bolton, these PROCEEDINGS, 50, 156 (1963).
7 Hoyer, B. H., B. J. McCarthy, and E. T. Bolton, Science, 144, 959 (1964).
8 Cowie, D. B., and B. J. McCarthy, these PROCEEDINGS, 50, 537 (1963).
9 Bolton, E. T. and B. J. McCarthy, J. Mol. Biol., 8, 201 (1964). 
'° McCarthy, B. J., and E. T. Bolton, J. Mol. Biol., 8, 184 (1964).
11 Hoyer, B. H., B. J. McCarthy, and E. T. Bolton, Science, 140, 1408 (1963).
12 Green, M., and M. Pifia, Virology, 20, 199 (1963).
13 Burgi, E., and A. Hershey, Biophys. J., 3, 309 (1963).
14 Huebner, R. J., W. P. Rowe, H. C. Turner, and W. T. Lane, these PROCEEDINGS, 50, 379
(1963).
15 Pereira, H. G., R. J. Huebner, H. S. Ginsberg, and J. Van Der Veen, Virology, 20, 613 (1963).
THE BINDING OF ESTRADIOL IN THE UTERUS:
A MECHANISM FOR DEREPRESSION OF RNA SYNTHESIS
BY G. P. TALWAR,* S. J. SEGAL, A. EVANS, AND 0. W. DAVIDSON
LABORATORIES OF THE POPULATION COUNCIL, ROCKEFELLER INSTITUTE
Communicated by E. L. Tatum, August 17, 1964
Several hormones stimulate the synthesis of RNA in specific target organs.-'3
Studies on the effect of growth hormone on liver, and estradiol on the uterus,2 3
show that the activation of RNA synthesis is an early metabolic event which pre-
cedes the synthesis of proteins (enzymes) and the increment in cytoplasmic mass.
Short pulse labeling and fractionation studies5'6 reveal that the stimulatory process
originates in the nucleus. The system is sensitive to inhibition by actinomycin D.
Moreover, the morphological manifestations of the hormone effect are dependent on
the initial stimulation of RNA synthesis and are prevented by inhibition of DNA-
dependent RNA synthesis.4
The manner in which hormones select target sites and activate the synthesis of
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RNA in these organs is not known. It is evident that target organs sequester the
appropriate hormone from the systemic circulation; some organs concentrate a
given hormone to a greater extent than others. For example, estradiol is rapidly
taken up by the uterus and the vagina.'4 The chemical identity of the hormone is
not altered in these tissues. Although quantitative studies are lacking to permit a
precise statement of the number of hormone molecules necessary to elicit a maxi-
mal response per unit cell, it is known that most hormones are effective when given
in very minute concentrations, in the order of a fraction of a microgram or pico-
gram. The facts that (a) the hormone localizes in specific organs and (b) it is con-
centrated by these organs from the systemic circulation even when the amount of
the circulating hormone is very low suggest the probable existence of specific "re-
ceptor" substances in target cells capable of recognizing a particular hormone.
This communication describes the subcellular localization of circulating estradiol-
17,3-6, 7-H3 in the ovariectomized rat uterus. A macromolecular fraction has been
obtained with which the hormone associates in vivo. When obtained from ovariec-
tomized rat uteri, this fraction is an inhibitor of RNA polymerase, while the same
fraction from animals given estradiol-17g has no inhibitory influence. Preincuba-
tion of the fraction with the steroid in vitro reverses its inhibitory effect on the
enzyme activity. The data suggest a dual role of this fraction as (a) a "receptor"
for fixation of the hormone in uterine cells and (b) a repressor of RNA polymerase in
the absence of the hormone, a property lost by its combination with the hormone.
Materials and Methods.-Radioactive compounds: Estradiol-17,3-6, 7-H3 with
specific activity of 41.3 curies/mM and cortisone-1, 2-H3 with specific activity of 721
inc/mM were obtained from New England Nuclear Corporation. Radiochroma-
tographic analysis of the steroids at the time of shipment showed the migration
of radioactivity in a single peak. Each batch of steroid was used within 3 weeks of
delivery. ATP-C14 was obtained from Schwarz BioResearch, Inc.
RNA polymerase assay: The enzyme was a purified preparation of E. coli
(courtesy of Dr. J. Hurwitz) and was assayed by standard procedure described
elsewhere. 15
Tissue preparation: Adult female rats of the Holtzman strain weighing between
180 and 200 gm and ovariectomized for at least 2 weeks were used. Vaginal smears
were taken on all animals to assure complete anestrus before they were placed on
experiment. Animals were sacrificed by decapitation and uteri removed, dissected
free of connective tissue and fat, and cut into small pieces in cold sucrose (0.88 M)
or buffer solution (TMK-tris, 10-2 M, pH 7.4; 1\IgCl2, 1.5 X 10-3 M; KC1, 10-2 M).
The tissue was homogenized in a glass hand homogenizer and filtered through cheese-
cloth. This homogenate is referred to as the total extract, which was subjected to
further fractionation as described in the footnotes of the tables and in the figure
captions.
Results.-Subcellular localization of estradiol-17f3-6, 7-H3 in the uterus: Subcu-
taneous doses of 0.3 tg of estradiol-6, 7-H3 were given to ovariectomized animals
twice daily for 3 days. On the fourth day a final dose of 0.3 jug was injected intra-
venously, and 1 hour later the uteri were removed and homogenized in 0.88 31
sucrose. The distribution of radioactivity (due to tritiated estradiol) in various
fractions is shown in Table 1. The counts are localized principally in a heavy
fraction (N) sedimenting at 1,500 g in 10 min and in the supernatant (S) obtained
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TABLE 1
LOCALIZATION OF ESTRADIOLA17,-6, 7-H3 IN SUBCELLULAR FRACTION OF
OVARIECTOMIZED RAT UTERUS
Expt. 1- -E xpt. 2 - - Expt. 3*
TCA insoluble, % of TCA insoluble. % of TCA insoluble, % of
Fraction cpm total cpm total cpm total
1. N (1,500g10/min) 3,080 28 4,550 28 14,655 39
2. M (20,000 g/30 min) 800 7 1,150 6 1,215 33. R(105,000g/75min) 1,500 14 1,600 10(pellet)
4. S(105,000g/75min) 5,500 51 9,200 56 21,960 58(supernatant)
0.3 jsg of estradiol-170-6, 7-H3 (45 puc) is administered subcutaneously to two ovariectomized rats twicedaily for 3 days. Uteri are removed on 4th day 1 hr after an intravenous injection of 0.3 jsg of labeled estradiol
and homogenized in 0.88 M sucrose. Subfractions are treated with cold TCA. The precipitates are dissolved
in 97% formic acid, and two aliquots of each are counted for radioactivity.
* 10 3M MgCl2 added to the homogenizing medium.
TABLE 3
TABLE 2 NATURE OF COUNTS IN THE 105,000 g
DISTRIBUTION OF ESTRADIOL-17l-6, 7-H3 IN SUPERNATANT
THE SUBCELLULAR FRACTIONS OF Per cent
OVARIECTOMIZED RAT UTERUS *Cpm of initial
FOLLOWING in vitro ADDITION 1. No treatment 1,750 100
Fraction Cpm X 10-2 2. TCA precipitate 280 16Fractioenae 6pX380- 3. pH 5 precipitate 301 171. Homogenate 6,380 4. Alcohol-ether (3:1) in-
2. N 2,200 soluble (one extrac-
3. R+M 210 tion) 110 6
4. S 3,260
One-ml aliquots of the supernatant (fraction S
Four ovariectomized rat uteri are homogenized in in Table 1) are treated with cold TCA or acidified
Tris 10-2 M pH 7.4 containing 1.5 X 10 M MgCl2 with HCI to pH 5. The precipitate is filtered on a
and 10-2 M KC1. 10 psl of estradiol-17,6-6, 7-Ha (0.01 Millipore membrane filter (pore size 0.45 M). The
Mg, 1.5 psc) is added to the homogenate with stirring. filter is dried and counted in a liquid scintillation
N is the pellet obtained at 750 g in 10 min, R + M counter. Another 1-ml aliquot is mixed with 5 ml
the pellet at 105,000 g for 30 min, and S the super- of alcohol-ether (3:1). The precipitate is dissolved
natant fraction. in hyamine hydroxide and counted.
after centrifugation at 105,000 g for 75 min. The radioactivity of the intermediate
fractions is low and becomes still lower if the uteri are homogenized in 0.88 M su-
crose containing 10-3 M MgCl2 (expt. 3, Table 1). Similar distribution patterns
are obtained if the estradiol-6, 7-H3 is added in vitro to ovariectomized rat uteri at
the time of homogenization (Table 2). Sixteen to seventeen per cent of the
estradiol radioactivity is precipitable with TCA or by acidification to pH 5 (Table
3). Almost all the estradiol present in this fraction is extractable with alcohol-
ether. It appears, therefore, that a substantial portion of the estradiol present in
the 105,000 supernatant of uterine cells is linked to macromolecular entities. The
linkage is not' covalent and lipid solvents can extract the steroid from its com-
bination with the macromolecular fractions.
Fractionation of the supernatant: After centrifugation at 105,000 g, the super-
natant was fractionated through a column of Sephadex G-100. Most of the radio-
activity of this fraction was identified with the first peak of the eluate material
having an absorbance at 280 mu (Fig. 1). This fraction is referred to hereafter
as the G-100-P.1 fraction. When estradiol is added in vitro to a homogenate of
ovariectomized rat uteri and the homogenate processed in the same manner as in
Figure 1, a peak of estradiol radioactivity appears associated with G-100-P.1
fraction. The free steroid (present in excess) is eluted at a later stage (Fig. 2).
The fixation of systemically administered estradiol in a nontarget organ such as
the lung is low. Identical fractionation of the 105,000 g supernatant from this organ
does not show the migration of estradiol-17,3-6, 7-H3 with the G-100-P.1 fraction
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FIG. 1.-Fractionation of 105,000 g supernatant. Four ovariectomized rats were given 0.3 ug
of estradiol-17,5-6, 7-H3 (45 uc) once daily for 3 days. Uteri were removed on the 4th day 1 hr
after an intravenous injection of 0.3 ug of radioactive estradiol. The tissues were homogenized
inTMK buffer pH 7.4 (Tris 10-2M, KC 0lo-a M, and MgCl2 1.5 X 10- M). Supernatant frac-
tion obtained after separation of particulate fractions at 750 g (10 min) and 105,000 g (45 min)
is fractionated through a column of Sephadex G-100 (2 cm diam. and 45 cm long). Each eluate
fraction measures 2.3 ml.
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FIG. 2.-Identification of estradiol (3-6, 7-H3 with the 105,000 g supernatant subfraction.
Twenty-five ovariectomized rat uteri were homogenized in TMK buffer to which 0.5 ,ug (75
uc) of estradiol 17(6-6, 7-H3 was added in vitro. Seven-ml fractions were collected during its
passage through Sephadex G-100 column used for experiment in Fig. 1.
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FIG. 3.-Fractionation of 105,000 g supernatant from a "nontarget" organ. Lungs from an
animal given estradiol were extracted as described under Fig. 1. The 105,000 g supernatant had
low radioactivity, to which was added 10-4 ,ug of estradiol-17,T-6, 7-H3 (10,000 cpm). Figure
shows the fractions obtained through Sephadex G-100 column used for the experiment in Fig. 1.
even after an in vitro loading of the supernatant with labeled estradiol (Fig. 3).
The "bound" estradiol elutes with the albumin-hemoglobin of blood origin (Fig. 3,
peak B). It appears, therefore, that the G-100-P.1 fraction from uterus contains
one (or more) components which bind estradiol, in vivo and in vitro, and that
macromolecules with these properties are not present in the lung preparation.
Properties of G-100-P.1: The G-100-P.1 fraction of ovariectomized rat uteri has
been tested for its capacity to bind estradiol-17# in vitro and for the specificity of
its steroid affinity. Varying concentrations of labeled steroids (estradiol-17B-6, 7-H3
and cortisone-i, 2-H3) were incubated with 0.2 ml G-100-P.1 (OD 1.65 per ml at
280 mM) at 37°C for 15 min. TCA was added to a final concentration of 5 per
cent. The steroid coprecipitated with the fraction was counted on a membrane
filter. Parallel steroid blanks without the macromolecular fraction were run for
each concentration of steroid to determine adsorption of free steroid on the mem-
brane filter. The net counts per minute are determined by subtracting the
value obtained for the steroid blanks from the G-100-P.1 plus steroid series (Table
4). Estradiol coprecipitates with the G-100-P.1 fraction in increasing amounts
from a concentration of 6 X 10-5 j.g in the medium to 2 X 10-2 Mg. With cortisone-
1, 2-H3, an input concentration of 6 X 10-2 yg fails to show binding in the TCA
precipitate. The specific activity of this concentration of cortisone is well above
that of binding concentrations of the tritiated estradiol. Only when the con-
centration of cortisone is increased to 0.125 Mg, 10,000-fold greater than the minimal
binding concentration for estradiol, can precipitable counts be discerned. It is
apparent that the G-100-P.1 fraction possesses greater capacity for fixation of es-
tradiol than of cortisone.
G-1i0-P. 1 and RNA synthesis: The influence of the G-100-P.1 fraction on RNA
polymerase activity is shown in Table 5. The polymerase is a purified preparation
from E. coli prepared by Dr. J. Hurwitz. Calf thymus DNA has been employed
as the template in the assay. The G-100-P.1 fraction inhibits the incorporation of
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TABLE 4
SPECIFICITY OF STEROID BINDING WITH UTERINE FRACTION G-100-P.1
Estradiol-6, 7-H3 added to Postincubation Cortisone-1, 2-Ha added to Postincubation
0.2 ml* TCA, ppt 0.2 ml* TCA, ppt
(fig) (JAC) (net cpm) (Og) (Mac) (net cpm)
0.02 0.3 16,528 0.125 0.2 245
0.01 0.15 9,300 0.062 0.1 0
0.006 0.1 5,512 0.0125 0.02 0
0.002 0.033 3,222 6.2 X 1O-3 10 X 1O-3 0
0.001 0.016 1,159 3.1 X 10-3 5 X 10-3 0
5 X 10-4 7.5 X 10-' 987 1.25 X 10-3 2 X 10-3 0
2 X 10-4 3 X 10-3 949 1.25 X 1O-4 2 X 10-4 0
1 X 10-4 1.5 X 10-3 640 6.25 X 10-5 10 X 10-5 0
6.6 X 10-5 1 X 10-3 450 3.1 X 10-5 5 X 10-5 0
2 X 10-5 3.3 X 10-4 7 1.25 X 10-5 2 X 10-5 0
5 X 10-6 7.5 X 10-5 11 1.25 X 10-6 2 X 10-6 0
2 X 10-6 3 X 10-5 0
1 X 10-6 1.5 X 10-5 0
6.6 X 10-7 1 X 10-' 0
2.2 X 10-7 3.3 X 10-6 0
* 0.2 ml G-100-P.1 (optical density 1.65 per ml at 280 mpA) incubated for 15 min at 370C with labeled steroid.
After addition of 5% TCA, preparation filtered on Millipore membrane filter (0.45 it pore size). A blank for each
steroid concentration (without G-100-P.1) treated similarly to assess the extent of adsorption of free steroid to
membrane. Net cpm derived by subtracting counts adsorbed on membrane of steroid blank from figure ob-
tained for G-100-P.1 plus steroid at same concentration.
TABLE 5
INFLUENCE OF UTERUS PREPARATION G-100-P.1 FROM OVARIECTOMIZED RATS
ON RNA POLYMERASE
Total nucleotide
G-l00-P.1 (ml) Cpm (100 X) incorporated (mpmoles)
1. Complete system 1,350 1.04
2. Plus G-100-P.1 0.1 1,190 0.92
3. " " 0.2 834 0.64
4. " " 0.3 544 0.41
.5. Minus RNA polymerase 0.3 54 0.1
Reaction mixture contained in 0.5 ml 80 m;smoles each of GTP, CTP, UTP, 136 mpmoles of ATP-C"4(6.4 X 106 cpm per ;smole), 2 ;smole MnCh, 1 Mmole of 2-mercaptoethanol, 25 pmoles of potassium maleatebuffer pH 7.5, 8 mgmoles of deoxyribonucleotides as calf thymus DNA, 5 X 10-5 M spermine tetrahydro-
chloride, and 1.6 units of purified E. coli RNA polymerase.
ribonucleotide triphosphates into polyribonucleotides in the system. A parallel
preparation from lung tissue has no inhibitory action (Table 6). The polymerase-
inhibiting activity of the uterine G-100-P.1 fraction is destroyed by heating for 10
min at 80'C (Table 7). The G-100-P.1 fraction from uteri of estrogen-treated
ovariectomized rats does not inhibit the enzyme activity (Table 7). The inhibition
caused by the G-100-P.1 fraction from ovariectomized animals is reversed by
preincubation with estradiol (Table 7) but not by cortisone.
Discussion and Conclusions.-The systemic administration of tritiated estradiol
to ovariectomized rats results in the localization of the hormone principally in two
subcellular compartments. Between 30 and 50 per cent of the radioactivity is
associated with the subcellular components that sediment at low speed. In most
tissues this fraction is composed of nuclei, cell membranes, unbroken cells, and
heavy particulate matter.
A substantial portion of the hormone is present also in the supernatant after
centrifugation at 105,000 g. The data indicate that the estradiol in this fraction is in
association with macromolecular entities. A partial purification has been at-
tempted to identify the specific "receptor" substance(s) for estradiol in the 105,000
g supernatant. The G-100-P.1 fraction has characteristics which suggest the
presence of one or more components having the capacity to bind estradiol-17,j
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TABLE 6
EFFECT OF G-100-P.1 FROM UTERI AND LUNGS OF OVARIECTOMIZED RATS
ON RNA POLYMERASE ACTIVITY
Nucleotide incorporated
G-100-P.1 (ml) Cpm (lOOX) (ATP) (mpmoles)
1. Complete system 960 0.88
2. Plus TMK buffer 0.3 1,200 1.08
3. PlusuterusG-100-P.1inTMKbuffer 0.3 310 0.276
4. Plus lung G-100-P.1 0.3 890 0.816
The reaction mixture (total volume 0.6 ml) contained the same amounts of constituents as in Table 6. The
optical density (absorbance) of uterus G-100-P.1 at 280 mp was 1.65 per ml and that of lung G-100-P.1 was
1.87 per ml.
TABLE 7
SPECIFICITY AND REVERSAL OF POLYMERASE-INHIBITING ACTIVITY
OF UTERINE G-100-P.1 FRACTION
ATP incorporated
System Cpm/0. 1 ml (mpmoles)
Expt. I
1. Control-complete system 490 0.46
2. + G-100-P.1 305 0.28
3. " preheated 800/10 min 725 0.68
4. " preincub./DNA 478 0.44
5. " + estradiol 0.03 ,ug 490 0.46
6. " + " 0.015Mg 557 0.57
7. " of " -treated rat 725 0.68
Expt. II
1. Control-complete system 1,681 1.21
2. + G-100-P.1 1,060 0.76
3. " + 0.03Mg estradiol 1,149 0.83
4. " + 0.03pyg preincub. 1,249 0.90
5. " + 0.015,Mgestradiol 1,465 1.06
6. " + 0.015 jug preincub. 1,391 1.05
Expt. III
1. Control-complete system 1,335 0.48
2. + G-100-P.1 1,035 0.37
3. " + estradiol 0.O1 jug 1,190 0.42
4. " + " 0.006 jg 1,321 0.47
Expt. IV
1. Control-complete system 720 0.67
2. + G-100-P.1 407 0.38
3. " + cortisone 0.06 ,g 379 0.344. " preheated 800/10 min 705 0.65
5. " of estradiol-treated rat 661 0.61
Assay system same as described under Table 6. Reaction volume 0.6 ml in expts. I, II, IV, and 0.3
ml in III. The specific activity of ATP-C14 in expts. I and IV was 6,400 cpm/m/A and 8,300 cpm/mp-
mole in expts. II and III.
in vivo and in vitro. Cortisone, a steroid hormone with no known direct biological
effect on the rat uterus, is not bound by the G-100-P.1 fraction except in very high
concentration.
In addition, the G-100-P.1 fraction prepared from ovariectomized rat uteri in-
hibits E. coli RNA polymerase activity. The inhibitory effect is lost if the prep-
aration is preheated at 800C for 10 min. The inhibitory factor is thus heat-]abile.
Heating destroys also the ability to bind the steroid. The G-100-P.1 fraction pre-
pared from the uteri of ovariectomized rats which received estradiol systemically
15 min or 1 hr before removal of the tissues has no inhibitory effect on the enzyme
activity. Preincubation with estradiol at 370C for 10 min reverses the inhibitory
capacity of the G-100-P.1 fraction from ovariectomized rat uteri at least partially.
Preincubation with cortisone does not result in reversal. These results suggest the
existence of a repressor of RNA polymerase in the G-100-P.1 fraction of the ovariec-
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tomized rat uterus, sensitive to derepression by binding estradiol in vivo or in vitro.
The same fraction contains a component(s) having affinity for the specific steroid,
responsible probably for the uptake of the hormone by the tissue. It is possible,
although not proved, that the two functions, i.e., that of "receptor" and "repressor,"
are inherent in the same molecule. It is obvious that the repression ofRNA synthe-
sis in situ would be occurring in the nucleus. The fraction described here has been
extracted from the supernatant and is a priori cytoplasmic. Its relation with the
nucleus is not yet established. Tables 1 and 2 show the fixation of the steroid in the
heavier fraction (containing the nuclei), which implies the presence of G-100-P. 1
or similar "receptor" substances, binding the hormone in this fraction. In the
absence of the hormone, the repressor would block the transcription of the genetic
information and keep the hormone-sensitive tissue in an atrophied state. The
uptake of the hormone by the tissue by means of the "receptor" function would
simultaneously release the repression of RNA synthesis, a system proposed lucidly
by Jacob and Monod16 for regulation of cellular metabolism in bacterial cells.
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